Massachusetts public health officials say some compounding pharmacies that were ordered to stop operations following unannounced inspections last year have submitted plans to address a range of violations. The surprise inspections were ordered last fall following the fungal meningitis outbreak caused by injections made and distributed by the New England Compounding Center in Framingham. According to the Centers for Disease Control and Prevention, the outbreak has been responsible for at least 45 deaths nationwide. The State Department of Public Health, or DPH, says 8 of the 11 sterile compounding pharmacies in Massachusetts that were issued either partial or complete cease-and-desist orders have submitted written plans of correction to the Board of Pharmacy. They include Baystate Home Infusion in Springfield and Western MA Compounding Center in West Springfield. The pharmacies still have to implement the corrective measures and perform renovations, if necessary, and then pass re-inspection before the cease-and-desist orders are dropped. Lenox Village Pharmacy in that western Massachusetts town has yet to submit a corrective plan. According to a statement by the DPH, another 21 pharmacies were cited for minor deficiencies that have since been corrected or are currently being addressed through corrective measures.